Syndicated Research Studies

Preclinical CRO Market Size & Trends The global preclinical CRO market size was valued at USD 5.72 billion in 2023 and is anticipated to grow at a CAGR of 8.7% from 2024 to 2030. Increased R&D budget for drug development is leading to rising demand for preclinical contract research organization (CRO) services, thus boosting the market growth during the forecast period. The surge in the number of preclinical trials involving large molecules and the growing need to curb R&D expense is expected to contribute to the growing demand for quality preclinical CRO. With regards to the COVID-19 vaccine, preclinical studies have been performed at an exponential speed, indicative of the overwhelming role of CROs. Increasing spending on CRO services is expected to boost the market growth significantly during the forecast period. The growing demand for drugs post COVID-19 is further contributing to the market growth. Different organizations across the globe have made significant fundin...

Preclinical CRO Market Growth & Trends The global  preclinical CRO market  size is expected to reach USD 10.26 billion by 2030, registering a CAGR of 8.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trends. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the market during the forecast period. However, the COVID-19 pandemic had temporarily affected the market owing to the shutdown of research sites due to the implementation of national lockdowns. Gather more insights about the market drivers, restrains and growth of the Global Preclinical CRO market The market is undergoing a series of mergers and acquisitions, resulting in improvement in full-service capabilities and the international reach of larger companies. For instance, in 2019, WuXi AppTec acquired Pharmapace. On the other hand, ...

Preclinical CRO Industry Overview The global preclinical CRO market size was valued at USD 4.87 billion in 2021 and is expected to advance at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030. Increased R&D budget for drug development is leading to rising demand for preclinical contract research organization (CRO) services, thus boosting the market growth during the forecast period. The surge in the number of preclinical trials involving large molecules and the growing need to curb R&D expense is expected to contribute to the growing demand for quality preclinical CRO. The ongoing COVID-19 pandemic initially disrupted preclinical research projects, especially during the first quarter of 2020. Nevertheless, lifesaving drugs are developing and are brought to market swiftly. Gather more insights about the market drivers, restrains and growth of the Global Preclinical CRO Market Over the years, there has been a significant change in the process of drug approval by...